Clinical Trials Directory

Trials / Conditions / Mild Cognitive Impairment Due to Alzheimer's Disease

Mild Cognitive Impairment Due to Alzheimer's Disease

11 registered clinical trials studyying Mild Cognitive Impairment Due to Alzheimer's Disease — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingAutophagy-Enhancers to Reduce Sleep Disturbances
NCT07383311
University Medicine GreifswaldN/A
RecruitingAssessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease
NCT06489548
Brigham and Women's HospitalPhase 2
Active Not RecruitingStudy to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Diseas
NCT06182085
PRInnovation GmbHPhase 2
Active Not RecruitingA Study to Learn About the Safety of BIIB080 Injections and Whether They Can Improve Symptoms of Participants
NCT05399888
BiogenPhase 2
Enrolling By InvitationUK Based Remote Brain Health Clinic (BHC) for Patients With Mild Cognitive Impairment (MCI)
NCT06379594
South London and Maudsley NHS Foundation Trust—
CompletedBiomarkers of Cognitive Impairment in Blood Cells
NCT05582941
University of the Balearic Islands—
UnknownEvaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects
NCT04141150
APRINOIA Therapeutics, LLCPhase 2
Completed[18F]APN-1607 PET in Subjects With AD Compared to HC
NCT05542953
APRINOIA TherapeuticsPhase 3
CompletedEvaluation of Safety of Contraloid Acetate in Patients With Mild Cognitive Impairment Due to Alzheimer's Disea
NCT04711486
Charite University, Berlin, GermanyPhase 1
TerminatedAD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Par
NCT02284906
TakedaPhase 3
TerminatedBiomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety
NCT01931566
TakedaPhase 3